NewcelX Ord Shs
NCEL3.549USD
-0.711-16.70%
Market hours （ET）Quotes delayed by 15 min
1.47MMarket Cap
--P/E TTM
More Details of Company
NewcelX Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of NewcelX Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+42.03%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+42.03%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
--
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
--
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Sarl (League Jann)
21.24%
Revel (Michel)
20.22%
Hafner (Ronald)
9.61%
Clover Wolf Capital - Limited Partnership.
7.53%
Twito (Ronen)
5.41%
Other
35.99%
Shareholders
Shareholders
Proportion
Sarl (League Jann)
21.24%
Revel (Michel)
20.22%
Hafner (Ronald)
9.61%
Clover Wolf Capital - Limited Partnership.
7.53%
Twito (Ronen)
5.41%
Other
35.99%
Shareholder Types
Shareholders
Proportion
Individual Investor
60.24%
Corporation
7.53%
Holding Company
3.54%
Investment Advisor
1.37%
Hedge Fund
0.32%
Other
27.01%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
16
76.72K
1.68%
-256.17K
2025Q3
18
206.03K
4.30%
-138.23K
2025Q2
20
223.48K
5.25%
-129.92K
2025Q1
19
232.05K
6.76%
-104.13K
2024Q4
19
214.25K
6.20%
-118.72K
2024Q3
20
351.93K
30.03%
-6.34K
2024Q2
20
303.17K
66.54%
+42.27K
2024Q1
18
293.95K
29.72%
+92.56K
2023Q4
17
148.27K
16.63%
-84.90K
2023Q3
17
159.86K
17.93%
-76.47K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Sarl (League Jann)
207.91K
5.78%
+207.91K
--
May 15, 2025
Revel (Michel)
189.01K
5.25%
+189.01K
--
May 15, 2025
Hafner (Ronald)
438.17K
9.61%
+129.67K
+42.03%
May 22, 2025
Alpha Capital Aktiengesellschaft
161.29K
3.54%
-85.71K
-34.70%
May 15, 2025
Grisard (Felix)
107.37K
2.36%
+107.37K
--
Oct 15, 2024
The Lind Partners, LLC
59.78K
1.31%
-43.75K
-42.26%
Dec 31, 2024
Konofal (Eric)
48.53K
1.06%
+48.53K
--
May 15, 2025
BVF Partners L.P.
143.68K
2.93%
--
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 25, 2024
Merger
40→1
Date
Type
Ratio
Sep 25, 2024
Merger
40→1
FAQs
Who are the top five shareholders of NewcelX Ord Shs?
The top five shareholders of NewcelX Ord Shs are:
Sarl (League Jann) holds 207.91K shares, accounting for 5.78% of the total shares.
Revel (Michel) holds 189.01K shares, accounting for 5.25% of the total shares.
Hafner (Ronald) holds 438.17K shares, accounting for 9.61% of the total shares.
Alpha Capital Aktiengesellschaft holds 161.29K shares, accounting for 3.54% of the total shares.
Grisard (Felix) holds 107.37K shares, accounting for 2.36% of the total shares.
Sarl (League Jann) holds 207.91K shares, accounting for 5.78% of the total shares.
Revel (Michel) holds 189.01K shares, accounting for 5.25% of the total shares.
Hafner (Ronald) holds 438.17K shares, accounting for 9.61% of the total shares.
Alpha Capital Aktiengesellschaft holds 161.29K shares, accounting for 3.54% of the total shares.
Grisard (Felix) holds 107.37K shares, accounting for 2.36% of the total shares.
What are the top three shareholder types of NewcelX Ord Shs?
The top three shareholder types of NewcelX Ord Shs are:
Sarl (League Jann)
Revel (Michel)
Hafner (Ronald)
Sarl (League Jann)
Revel (Michel)
Hafner (Ronald)
How many institutions hold shares of NewcelX Ord Shs (NCEL)?
As of 2025Q4, 16 institutions hold shares of NewcelX Ord Shs, with a combined market value of approximately 76.72K, accounting for 1.68% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -2.61%.
What is the biggest source of revenue for NewcelX Ord Shs?
In --, the -- business generated the highest revenue for NewcelX Ord Shs, amounting to -- and accounting for --% of total revenue.
